🇺🇸 FDA
Patent

US 7253171

Urea derivatives as integrin α4 antagonists

granted A61PA61P1/04A61P11/00

Quick answer

US patent 7253171 (Urea derivatives as integrin α4 antagonists) held by Laboratories Almirall, S.A. expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Laboratories Almirall, S.A.
Grant date
Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/02, A61P11/06